FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16263311000001102: Tavanic 500mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57309601000001112 Tavanic 500mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57309701000001119 Tavanic 500mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tavanic 500mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Is a Product containing precisely levofloxacin 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has active ingredient Levofloxacin false Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has specific active ingredient Levofloxacin hemihydrate false Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Levofloxacin true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Is a Tavanic true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has specific active ingredient Levofloxacin hemihydrate true Inferred relationship Existential restriction modifier
Tavanic 500mg tablets (Lexon (UK) Ltd) Has basis of strength substance Levofloxacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tavanic 500mg tablets (Lexon (UK) Ltd) 10 tablet Has AMP True Tavanic 500mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start